Showing posts with label p16. Show all posts
Showing posts with label p16. Show all posts

Tuesday, 4 March 2025

Cellular Alterations and Immunohistochemical Expression of p53 and p16 in the Oral Mucosa of Saudi Smokers: A Cross-Sectional Study | Chapter 9 | Achievements and Challenges of Medicine and Medical Science Vol. 7

Background: Smoking is a well-known risk factor for various health problems, including oral cancer. P16 and P53 proteins are involved in cell cycle regulation and proliferation, and their expression levels can provide insights into cellular health. Several studies using different methods, like cytological assessment, DNA damage detection, and histological investigations, have looked at how cells change in the oral mucosa of smokers.

Objective: This study aims to evaluate the cellular changes and immunohistochemical expression of p53 and p16 in the oral mucosa among Saudi smokers.

Methods: From 2022 to 2023, 1000 samples from the buccal mucosa were collected in a cross-sectional study. All the participants included in the study's participants were Saudi citizens of both genders. Seven hundred cigarette smokers and 300 non-smokers made up the controls, using two sampling techniques: initially purposive and then snowball sampling. Both smokers and nonsmokers appeared to be in fair health, with ages ranging from 18 to 85 years. The materials were subjected to immunohistochemical analysis for P16 and P53 protein overexpression. The samples were scored based on the percentage of positively stained cells and staining intensity. The data were analyzed using SPSS (including the software version), and categorical variables were identified as frequencies and percentages using the chi-squared test; a value of P<0.05 was considered significant.

Results: This study is an investigation of the classification of participants based on gender and age group, as well as the cytopathological changes observed in cigarette smokers compared to nonsmokers. Cigarette smokers demonstrated significantly higher rates of cytological inflammation, reverse cytological infection, atypia, and binucleated/multinucleated cells compared to non-smokers, with an overall abnormal result rate of 46% versus 18.7%, respectively (P = 0.024). The study found higher P53 and P16 expression among smokers (7.14% and 2.14%, respectively) compared to non-smokers (0.1% and 0.33%) (P = 0.038). No significant differences were observed in P53/P16 expression across age groups (P = 0.72) or between male and female participants (P = 0.25).

Conclusion: These findings highlight the detrimental effects of smoking on cellular health and reinforce the importance of smoking cessation in reducing the risk of developing cytological abnormalities and associated diseases. These results highlight the association of smoking with increased biomarker expression, emphasizing its relevance in understanding oral health risks. This is a cross-sectional study which limited to establishing causality between smoking and the observed cytopathological changes. Future longitudinal studies are needed to examine whether these cellular changes persist over time and assess their impact on disease development.

 

Author (s) Details

 

Faris M Elmahdi
Department of Basic Medical Science, Al Rayan National College of Medicine, Alrayan Colleges, Al-Madina Al-Munawara, Kingdom of Saudi Arabia.

 

Lama S Alahmadi
College of Medicine, Medical Students, Alrayan Colleges, Al-Madina Al-Munawara, Kingdom of Saudi Arabia.

 

Saada S Alharbi
College of Medicine, Medical Students, Alrayan Colleges, Al-Madina Al-Munawara, Kingdom of Saudi Arabia.

 

Rahaf Abdulla
College of Medicine, Medical Students, Alrayan Colleges, Al-Madina Al-Munawara, Kingdom of Saudi Arabia.

 

Abdulrahman L Alanzi
College of Medicine, Medical Students, Alrayan Colleges, Al-Madina Al-Munawara, Kingdom of Saudi Arabia.

 

Sumia S. Kabee
Department of Basic Medical Science, Al Rayan National College of Medicine, Alrayan Colleges, Al-Madina Al-Munawara, Kingdom of Saudi Arabia.

 

Please see the book here:- https://doi.org/10.9734/bpi/acmms/v7/3205

Friday, 22 March 2024

Pathological and Immunohistochemical Studies on Horn Cancer in Bovines | Chapter 6 | Advanced Research in Biological Science Vol. 9

Background: An investigation was carried out on twelve clinical cases of neoplasm of horn in bovines of Durg, Dhamtari and Rajnandgaon districts of Chhattisgarh suspected of bovine horn core carcinoma (squamous cell carcinoma) revealed the cytology, pathomorphology and immunohistochemical (IHC) expression of Pan-cytokeratin (Pan-CK), p53 gene, epidermal growth factor receptor (EGFR) and p16 gene in tumourous growth at horn in bovines.

 

Results: Eight out of 12 cases (66.66%) were confirmed as SCC of horn on the basis of histopathological and immunohistochemical analysis. Cytological examination of tumours by Papanicolaou staining revealed variation in shape and size of cells and altered nuclear details. Grossly neoplasms of horn revealed unilateral large cauliflower like growths at the base. SCCs were classified as well, moderately and poorly differentiated types on the basis of histopathology and immunohistochemistry (IHC). Well differentiated SCCs (n=4; 50%) were characterized by severe keratinization of horn epithelium with concentric arrangement forming keratin pearls also called as “cell nests”. Tumour islands of irregular shape observed in the horn epithelium invaded deep into dermis layer. Moderately differentiated SCCs (n=2; 25%) characterized by small keratin pearl formations and mitotic figures. Poorly differentiated SCCs of horn (n=2; 25%) revealed absence of distinctive keratin pearls although deep invasion from primary site was observed. SCC of horn revealed strong immunohistochemical staining of Pan-CK, p53 and EGFR and negative to p16. Highest immunohistochemical expression was observed in Pan-CK which confirmed the tumours were of epithelial origin and EGFR immunoexpression was confirmatory for malignancy and degree of metastasis. Neoplasms were confirmed as SCC by immunoexpression of Pan-CK, EGFR and p53 in malignant tumours including both well and poorly differentiated SCC of horn.


Author(s) Details:

Vivek Kumar,
Department of Veterinary Pathology, Dau Shri Vasudev Chandrakar Kamdhenu Vishwavidyalaya, Anjora, Durg- 491001, Chhattisgarh, India.

Dhananjay Kumar Jolhe,
Department of Veterinary Pathology, Dau Shri Vasudev Chandrakar Kamdhenu Vishwavidyalaya, Anjora, Durg- 491001, Chhattisgarh, India.

Ratan Chandra Ghosh,
Department of Veterinary Pathology, Dau Shri Vasudev Chandrakar Kamdhenu Vishwavidyalaya, Anjora, Durg- 491001, Chhattisgarh, India.

Rukmani Dewangan,
Department of Veterinary Surgery & Radiology, Dau Shri Vasudev Chandrakar Kamdhenu Vishwavidyalaya, Anjora, Durg- 491001, Chhattisgarh, India.

Prashant M. Sonkusale,
Department of Veterinary Pathology, Nagpur Veterinary College, Maharashtra Animal & Fisheries Science University, Nagpur- 440007, Maharashtra, India.

Sonu Sharma,
Dr. Lal Path Labs, Path Vets Veterinary Diagnosis, Chittranjan Park, New Delhi-110019, India.

Please see the link here: https://stm.bookpi.org/ARBS-V9/article/view/13646